Atlas Trials

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole

Clinical trial NCT04604795 · COMPLETED

Trial details

NCT number
NCT04604795
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Celiac DiseaseCoeliac Disease
Start date
2020-11-04
Primary completion
2021-06-29
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.